Malaysia Begins Phase 3 Trails Of China Developed COVID-19 Vaccine
Faizan Hashmi Published January 27, 2021 | 02:44 PM
Malaysia has begun a phase 3 clinical trial of a COVID-19 vaccine candidate developed by the Institute of Medical Biology of the Chinese Academy of Medical Sciences (IMBCAMS), the Health Ministry said on Wednesday
KUALA LUMPUR, (APP - UrduPoint / Pakistan Point News - 27th Jan, 2021 ) :Malaysia has begun a phase 3 clinical trial of a COVID-19 vaccine candidate developed by the Institute of Medical Biology of the Chinese academy of Medical Sciences (IMBCAMS), the Health Ministry said on Wednesday.
The initiative is a collaboration between the governments of Malaysia and China to generate scientific data in the development of the vaccine candidate to evaluate its safety and efficacy against COVID-19 infection, the ministry said in a statement.
The trials will involve nine government hospitals across Malaysia and 3,000 volunteers for a period of 13 months.
In his speech during the virtual launching ceremony, Malaysian Health Minister Adham Baba said Malaysia is very pleased to work with China, through IMBCAMS in contributing to the search for scientific evidence in the development of the inactivated vaccine.
"With strong regulatory, certified researchers and experienced research sites, we are confident of producing quality scientific evidence to support the research vaccine," he said.
"This cooperation will strengthen ties between China and Malaysia. I am very confident that we will have more opportunities to work together in the near future, bringing more positive results not only for both our countries, but also for the world," Adham said.
For his part, Che Yanchun, head of the R&D Department, Chinese Institute of Medical Sciences Academy of Medical Sciences, said Malaysia has been chosen as the first country outside China to participate in this phase 3 clinical trial of the COVID-19 vaccine which would also take place in other countries.
"I sincerely hope the phase 3 clinical trial in Malaysia will be a successful one, and it will fulfill the objectives of the clinical trial, and certainly Malaysia will also get the benefits from this trial," Che said.
Related Topics
Recent Stories
Robinson, bowlers help New Zealand go 2-1 up against Pakistan
Shahzeb Chachar to hold khuli kachehri on April 26
Heatwave amid Israel's aggression in Gaza brings new misery, disease risk
Tourism must change, mayor says as Venice launches entry fee
Court adjourns Judicial Complex attack case till May 17
Nasreen Noori’s book ‘Popatan Jahra Khwab’ launched
Wafaqi Mohtasib inspection team visits Excise and taxation office
AJLAC announces 5th Conference titled ‘People’s Mandate: Safeguarding Civil ..
Pak-US officials engage to enhance trade, investment ties
IBCC to promote educational excellence, expand regional presence
Pakistani 'Blue Helmets' serving UN Peacekeeping Mission in DR Congo set to leav ..
Putin says plans to visit China in May
More Stories From World
-
Slot 'confident' of Liverpool job as 'negotiations' take place
2 hours ago -
Google parent Alphabet's Q1 profits beat estimates: company
2 hours ago -
WADA asks 'independent prosecutor' to examine Chinese swimmers case
2 hours ago -
New York court overturns Harvey Weinstein sex crime conviction
3 hours ago -
Bagnaia and Spanish rivals chase victory at Jerez
4 hours ago -
Russian, Ukrainian strikes kill at least 10 in frontline regions
4 hours ago
-
Heatwave amid Israel's aggression in Gaza brings new misery, disease risk
5 hours ago -
Tourism must change, mayor says as Venice launches entry fee
5 hours ago -
Pakistani 'Blue Helmets' serving UN Peacekeeping Mission in DR Congo set to leave after 20 years of ..
5 hours ago -
Putin says plans to visit China in May
5 hours ago -
US reinstates open internet rules rescinded under Trump
5 hours ago -
Honda announces US$11 bn EV battery and vehicle plant in Canada
6 hours ago